' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Treatment of vertebral artery origin stenosis with a Pharos stent device: a single center experience.
Broussalis, E; Kunz, AB; Luthringshausen, G; Klein, S; McCoy, MR; Trinka, E; Killer-Oberpfalzer, M;
Interv Neuroradiol. 2011; 17(3): 316-322.
Originalarbeiten (Zeitschrift)

PMU-Autor/inn/en

Killer-Oberpfalzer Monika
Kunz Alexander
Luthringshausen Gernot
McCoy Mark R.
Müller-Thies-Broussalis Erasmia
Trinka Eugen

Abstract

Atherosclerotic stenosis of vertebral artery (VA) origin exceeding 70% severity accounts for one third of all vertebrobasilar strokes. For a period of one year the results of endovascular treatment of VA stenosis with the new Pharos stent device were assessed.Twenty-two patients with symptomatic VA stenosis were treated with the Pharos stent. Clinical status and stenosis grade were documented before treatment and 24 hours, one, three and twelve months after treatment via ultrasound and magnetic resonance tomography.All procedures proved to be technically successful without the occurrence of intra-procedural complications. During the observation period of more than one year, 55% of patients were documented with a mean stenosis degree of 60%: two (10%) of these patients showed a residual stenosis after angioplasty and nine patients (45%) an in-stent restenosis, whereas only two patients were documented with a hemodynamically relevant in-stent restenosis of 80%. These two patients were retreated with balloon dilatation. None of the patients showed neurological deterioration or new abnormalities at magnetic resonance tomography examination. Neither VA occlusion nor restenosis of the contralateral VA negatively affected the clinical outcome. An in-stent restenosis was developed by more female than male patients.VA origin stenting with the Pharos stent device is an effective treatment of stenosis. The good clinical results compared to the high restenosis rates have to be examined in further studies. Pin particular, it has to be determined whether the Pharos stent allows the vessel time for collateralization, whether double antiplatelet treatment prevents recurrent cerebrovascular events or whether merely the low restenosis degree is causative for the clinical outcome.


Useful keywords (using NLM MeSH Indexing)

Aged

Aged, 80 and over

Cerebral Angiography

Cerebral Revascularization/instrumentation*

Cerebral Revascularization/methods*

Female

Follow-Up Studies

Humans

Male

Middle Aged

Severity of Illness Index

Stents*

Treatment Outcome

Vertebrobasilar Insufficiency/radiography

Vertebrobasilar Insufficiency/therapy*


Find related publications in this database (Keywords)

vertebral artery origin stenosis
stent
Pharos
posterior circulation stroke